Why List All Current Medications Before Starting Cosentyx?
Yes, always disclose every medication, supplement, and over-the-counter drug you're taking when prescribed Cosentyx (secukinumab). This IL-17A inhibitor treats conditions like psoriasis, psoriatic arthritis, and ankylosing spondylitis, but it carries risks of serious infections and immune suppression that can worsen with certain drug combinations.[1]
Key Drug Interactions to Watch For
Cosentyx interacts with:
- Live vaccines (e.g., MMR, varicella)—avoid during treatment and for weeks after.[1]
- Immunosuppressants like TNF blockers (e.g., Humira, Enbrel) or methotrexate—increases infection risk; often not used together.[1][2]
- CYP450-metabolized drugs (e.g., statins, oral contraceptives)—Cosentyx may alter their levels indirectly via inflammation changes.[2]
- Biologics or DMARDs—switching requires washout periods to prevent overlapping effects.[1]
Prescribers use this info to adjust doses, sequence therapies, or run tests like TB screening.
What Happens If You Don't Disclose?
Omitting details can lead to undetected interactions causing severe infections (e.g., tuberculosis reactivation), allergic reactions, or reduced efficacy. FDA labeling mandates full disclosure; lawsuits have arisen from nondisclosure in biologic cases.[1][3]
Who Reviews This Information?
Rheumatologists, dermatologists, or primary prescribers check against Cosentyx's label and databases like Lexicomp. Pharmacists verify at dispensing and flag issues via systems like Epocrates.[2]
Common Patient Questions on Timing and Follow-Ups
- When exactly? At the initial consult, before the first loading dose (300mg weekly for psoriasis).[1]
- Supplements too? Yes—e.g., St. John's wort or high-dose fish oil can affect immune response or drug levels.[2]
- What if meds change later? Update your doctor immediately; Cosentyx requires ongoing monitoring.[1]
- Pregnancy or other conditions? Disclose fully—Cosentyx is Pregnancy Category B, but interactions with hormones matter.[1]
Patients report better outcomes when transparent, per clinical guidelines from the American College of Rheumatology.[3]
Sources:
[1] Cosentyx Prescribing Information (Novartis)
[2] Drugs.com - Cosentyx Interactions
[3] FDA Label for Secukinumab